PFBT
PRME icon

Parkside Financial Bank & Trust’s Prime Medicine PRME Stock Holding History

Parkside Financial Bank & Trust’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$992 Hold
285
– – ﹤0.01% 2363
2025
Q4 		$989 Hold
285
– – ﹤0.01% 2347
2025
Q3 		$1.58K Hold
285
– – ﹤0.01% 2106
2025
Q2 		$700 Buy
+285
New +$439 ﹤0.01% 2383

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Parkside Financial Bank & Trust's PRME Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its Prime Medicine (PRME) position steady in Q1 2026 at 285 shares worth $992. The position accounts for ﹤0.01% of the portfolio, ranked #2363.

Parkside Financial Bank & Trust first reported a position in PRME in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.58K in Q3 2025. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Parkside Financial Bank & Trust held 285 shares of Prime Medicine worth $992 as of Q1 2026.
  • Parkside Financial Bank & Trust left its Prime Medicine share count unchanged in Q1 2026.
  • Prime Medicine made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2363 holding.
  • Parkside Financial Bank & Trust first reported a position in Prime Medicine in Q2 2025 and has held it in 4 quarters since.
  • Parkside Financial Bank & Trust's Prime Medicine position peaked at $1.58K in Q3 2025.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.